X
15Dec

Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment

The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By: McDermott Will & Emery
Source Url: https://www.jdsupra.com/legalnews/life-sciences-dealmaking-symposium-30857/

Related

An Ounce of Prevention Is Worth a Pound of Cure: California DFEH Clarifies Sexual Harassment Prevention Training Requirements

California’s Department of Fair Employment and Housing (“DFEH”) has updated its Employer FAQ guid...

Read More >

SPAC Litigation Likely to Surge in 2021

Despite the challenges posed by COVID-19, 2020 saw an eruption of IPOs by special purpose acquisitio...

Read More >

Greater Access to Mental Health Care is on the Horizon

Employers and retail giants alike are increasingly inserting mental health into the broader, public ...

Read More >

Employers Should be Prepared to Deal with Coronavirus

With the worldwide cases of coronavirus tripling in the past week, and the eleventh case confirmed i...

Read More >

New Laws in New Jersey Significantly Enhance Risks for Companies Using Independent Contractors

New Jersey Governor Phil Murphy signed six bills into law on January 20, all targeting the use of in...

Read More >

Transportation and logistics trends to watch in 2021

In the age of globalization and international trade, transportation and logistics have become hot to...

Read More >